A cute ST-segment-elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality. Early myocardial reperfusion with thrombolytic therapy and primary percutaneous coronary intervention with coronary stents are effective at limiting cardiac infarction size; however, reperfusion itself can cause further cardiomyocyte death.
resident cardiac macrophages that would otherwise be subject to ischemia-induced cell death. 15, 16 The causal contribution of these resident phagocytes to phagocytosis-linked cardiac protection is of particular interest, as emerging I/R strategies block recruited monocytes/macrophages from the circulation, [17] [18] [19] [20] [21] [22] leaving embryonic-derived CCR2 − (C-C motif chemokine receptor type 2) resident macrophages intact. 16, 23 Herein, we uncover a critical biomarker for compromised phagocytosis in post-STEMI humans, that is, solMER. In this context, it was important for us to test the causal contribution of phagocytosis to clinically relevant myocardial reperfusion injury, as well as the implications of MerTK cleavage in mice and humans after cardiac reperfusion and in resident CCR2 − cardiac macrophages. Taken together, our findings implicate monocyte-induced MerTK cleavage on proreparative MHCII LO (major histocompatibility complex II) cardiac macrophages as a novel contributor and therapeutic target of reperfusion injury.
Methods
Additional Materials and Methods are in the Online Data Supplement.
Statistics
Statistical analyses were performed with GraphPad Prism (GraphPad Software, La Jolla, CA). Comparisons between 2 groups were performed using 2-tailed, unpaired t test with 95% confidence interval. For comparisons of more than 2 variables, analysis of variance was used with 95% confidence interval. Data are presented as mean±SEM.
Results

Post-Reperfusion Phagocytosis by MerTK Is an Important Mediator of Cardiac Repair Shortly After MI
I/R activates the innate immune response in a unique way and has been correlated with depressed phagocytosis, 24 a rate-limiting step to tissue repair. To assess determinants of phagocytosis efficiency after cardiac I/R, we fist evaluated overall murine cardiac macrophage (CD11b + phagocytes 4 hours after reperfusion in Mertk +/+ mice, and internalization was confirmed by confocal microscopy (Online Figure IB) . Cardiac extracts prepared in the presence of cytochalisin D, 25 a phagocytosis inhibitor, also demonstrated reperfusion-dependent phagocytosis and indicated that postextract mCherry uptake accounted for <20% of events (Online Figure IC) . To test the significance of clinically relevant reperfusion-associated phagocytosis in heart, mice deficient for phagocytic receptor gene Mertk were used. 26 
Mertk
+/+ and Mertk −/− mice were subjected to I/R and examined for infarct size, efferocytosis, inflammation, and cardiac function. Reperfusion-specific clearance of mCherry + cardiomyocytes within the ischemic area at risk was nearly eliminated in Mertk −/− hearts post-I/R, implicating MerTK protein as a dominant phagocytic receptor in the early hours after reperfusion ( Figure 1A ; Online Figure IA) . Interestingly, Mertk-dependent phagocytosis was also reduced, to a lesser extent, under steady state conditions. Importantly, MerTK was not detectable on either neutrophils or Ly6C hi F4/80 lo monocytes, and in line with this, Mertk deficiency did not impair phagocytosis of cardiomyocyte debris in either cardiac neutrophil nor monocytic subsets (Online Figure II) . Impairments of early phagocytosis in Mertk −/− mice were also linked to early elevations in cardiac troponin levels (>20%; Figure 1B ), as well as increases in infarct size ( Figure 1C ). Similar findings were made after performing I/Rs in LysM-Cre + Mertk fl/fl mice (Online Figure III) , in which Mertk deletion is restricted to myeloid cells. Defective phagocytosis also preceded the delayed resolution of total noncardiomyocyte inflammatory cell numbers in heart (Online Figure  IV) , heightened ratios and numbers of peripheral inflammatory Ly6C hi cardiac phagocytes (Online Figure V) , and neutrophils (Online Figure VI) . These acute effects of Mertk deficiency translated into left ventricular dilatation, reduced cardiac systolic function ( Figure 1D ), and enlarged (by 15 
Novelty and Significance
What Is Known?
• Therapies to reduce myocardial ischemia reperfusion injury are lacking.
• Immune cell macrophages remove dying cardiomyocytes via phagocytic receptors to enhance cardiac repair.
What New Information Does This Article Contribute?
• Phagocytic clearance is a significant contributor to cardiac repair after myocardial ischemia reperfusion.
• Clinical reperfusion seems to impair the function of the phagocytic receptor MerTK (myeloid-epithelial-reproductive tyrosine kinase).
• Strategies that block reperfusion-associated MerTK dysfunction improve cardiac function.
The significant findings of our study include the causal implication of immune cell-mediated phagocytic removal of dying cardiomyocytes, specifically after repefusion of heart attacks. The findings in humans suggest that this beneficial phagocytic pathway is impaired after myocardial reperfusion and that this occurs by the cleavage of a phagocytic receptor called MerTK. After engineering cleavage-resistant forms of MerTK, cardiac function after reperfusion was enhanced, implicating (1) MerTK cleavage as a biomarker of poor cardiac repair and (2) the therapeutic potential in heart of strategies that inhibit MerTK cleavage.
P<0.04) fibrotic scars. Taken together, these data reveal the importance of phagocytosis and macrophage MerTK during the early perioperative hours of the cardiac I/R response. In this context, we next asked whether myocardial IRI might act in part through antagonism of proreparative phagocytosis and MerTK.
Inhibition of MerTK Cleavage Improves Cardiac Repair After Reperfusion
Reperfusion injury compromises the efficacy of percutaneous coronary intervention 27 and may directly interfere with MerTK-dependent cardiac repair. For example, reactive oxygen species, a common component of I/R, induces proteolytic cleavage of MerTK, leading to MerTK dysfunction and appearance of the stable cleavage product called solMER. 9 We first examined human STEMI patients (Online Table I ) for evidence of solMER. In contrast to patients with stable coronary vascular disease, STEMI patients had elevated serum sol-MER levels ( Figure 2A) . Similar results were found in mice post-I/R, where solMER levels were significantly heightened ( Figure 2B ), concomitant with reduced cell surface MerTK levels (mean fluorescence intensity) on CD11b + Ly6C lo macrophages ( Figure 2C ). To test the significance of MerTK cleavage, we studied gene-targeted mice (MertkCR/CR) in which the proteolysis site of MerTK has been deleted, 8 leading to replacement of the wild-type MerTK with fully functional but cleavage-resistant MerTK. These mice produced reduced levels of solMER ( Figure 2D ) and maintained cardiomyocyte efferocytosis post-I/R ( Figure 2E ). Relative to Mertk +/+ mice, infarct sizes were reduced in MertkCR/CR mice ( Figure 2F ), and this was associated with improved left ventricular function ( Figure 2G ).
Furthermore, quantification of inflammatory cell populations in the infarct 3 days after I/R revealed a significant increase in neutrophils and Ly6C hi monocytes in Mertk 
CCR2 − Resident Macrophages Can Participate to Suppress Infarct Size Through MerTK
Strategies that block recruited monocytes from the circulation post-I/R have been shown to ameliorate infarct size. 17, 23 In the absence of recruited phagocytes, resident phagocytes may be important during efferocytosis-mediated repair. Indeed, analysis of early phagocytic clearance (6 hours post-I/R) identified a population of phagocytic CCR2 − cardiac macrophages that were more phagocytic, that is, they showed increased accumulation of myocyte mCherry relative to CCR2 + macrophages ( Figure 4A) . A time course analysis ( Figure 4B ) showed that Figure 4D ), prior to the accumulation of most monocyte-derived macrophages. On deeper inspection of cardiac phagocyte subsets, and using previously published gating schemes, 16 we were able to distinguish between recruited Ly6C hi monocytes and F4/80 + Ly6C lo resident macrophages, which were further distinguished by MHCII and CCR2 expression (Online Figure VII) . Interestingly, MerTK was significantly higher on MHCII 
Role for MerTK on CCR2 − Resident Macrophages in Control of Infarct Size Post-I/R
To test the potential role of resident cardiac macrophages to infarct size, we blocked recruitment of monocytes ( Figure 5A ) with a CCR2 chemokine receptor antagonist RS504393, 28 which did not affect the resident macrophage populations. Although RS5043934 treatment reduced infarct size in Mertk +/+ mice, it did not affect the increased infarct size seen with Mertk −/− mice ( Figure 5B ). Similar results were found when infarct sizes in Mertk −/− mice were normalized to Mertk +/+ mice ( Figure 5B , right panel). We also examined this in Ccr2 −/− mice. As expected, Ccr2 −/− mice had diminished recruitment of Ly6C hi monocytes ( Figure 5C and 5D) and neutrophils ( Figure 5E ) after I/R but similar total number of macrophages compared to Ccr2 +/+ mice ( Figure 5F ). Furthermore, infarct size was elevated in Ccr2
Mertk
−/− double knockout mice relative to Ccr2 −/− control ( Figure 5G ). These data suggest that cardiac resident macrophages, through MerTK, can contribute to cardiac repair after I/R.
CCR2-Dependent Mechanism of MerTK Cleavage Post I/R
As mentioned earlier, CCR2-dependent blockade of recruited monocytes from the circulation ameliorate cardiac I/R. 17, 23 Given our finding of Mertk-dependent phagocytosis by CCR2 − phagocytes (Figure 4) , we next considered the hypothesis that a contributing mechanism of recruited monocyte-dependent reperfusion injury is through the transactivation of MerTK cleavage on resident CCR2 − cardiac macrophages. If this is indeed the case, Ccr2 deficiency should lead to both reduced solMER post-I/R, as well as protected cell-surface MerTK, specifically on the surface of CCR2 − cardiac macrophages. Consistent with this rationale, Ccr2-deficient mice, subjected to cardiac I/R, generated significantly reduced levels of solMER ( Figure 6A ). Importantly, this CCR2-dependent response was preceded by protection of cell surface MerTK levels on total CCR2 − cardiac macrophages ( Figure 6B ), which included both the MHCII HI ( Figure 6C ) and MHCII LO ( Figure 6D ) subsets, consistent with recruitment of CCR2-dependent monocytes promoting MerTK cleavage on resident phagocytes.
Mertk Is Required for Both MHCII LO Phagocyte Cell Maintenance and Anti-Inflammatory Cytokine Production
Having discovered a greater dependence of MHCII LO phagocytes for Mertk-dependent phagocytosis, relative to MHCII HI phagocytes (Figure 4) , we turned our attention to potential cell-intrinsic consequences on anti-inflammatory cytokine production, a known molecular output, secondary to the engulfment of apoptotic cells. 29 To examine the cell-intrinsic potential for anti-inflammatory cytokine expression, we isolated by fluorescence-activated cell sorter cardiac phagocytes that were engaged in wound healing, that is, mCherry HI counterparts, expressed elevated levels of anti-inflammatory mediators, IL-10 and TGF-β ( Figure 7A ). These findings could be recapitulated ex vivo after isolating cardiac resident macrophages and directly feeding apoptotic cells at equal ratios of apoptotic cells to phagocyte ( Figure 7B ). Importantly, anti-inflammatory TGF-β expression by cardiac macrophages required MerTK ( Figure 7C ). These data are consistent with enhanced Mertk-dependent resolution of cellular inflammation post-I/R (Figure 3) . Interestingly, this Mertk-dependent polarized function between MHCII LO and MHCII HI macrophages extended to the ratio of these 2 cell subsets relative to one another. For example, at steady state, MHCII LO phagocytes were largely absent in Mertk −/− mice ( Figure 7D ), with increased ratios of MHCII HI to MHCII LO cardiac macrophages enumerated. A similar skewed ratio was found post-I/R ( Figure 7E through Figures  VIII and IX) . Thus, our findings reveal Mertk-and phagocytosis-dependent anti-inflammatory roles during the progression Figure 7D ). Importantly, these Mertk-dependent processes are naturally antagonized in mice and humans during reperfusion by MerTK cleavage (Figure 2) , implicating a new target for both the amelioration of cardiac reperfusion injury and the potential enhancement of cardiac repair (Figure 8 ).
Discussion
Herein we describe a mechanism that limits the therapeutic benefits of myocardial reperfusion after ischemia. This occurs through I/R-induced inhibition of macrophage-mediated phagocytic repair. Proteolytic cleavage of the cell surface apoptotic cell receptor MerTK restricts the capacity of cardiac macrophages to clear dead cardiomyocytes after I/R. MerTK cleavage also impairs MerTK-dependent anti-inflammatory signaling in resident cardiac macrophages. Based on our cumulative data and previous literature, we propose a working model of our findings (Figure 8 ). Although implicated in other diseases, such as atherosclerosis, 10 the significance and therapeutic potential of phagocytosis, MerTK, and MerTK cleavage in reperfused hearts is unique. The nonrenewable cell cycle of adult differentiated cardiomyocytes renders the post-MI heart particularly sensitive to delays in efficient phagocytic healing. High levels of inflammatory necrotic and apoptotic cardiomyocytes set the stage for prolonged inflammation. If dying cardiomyocytes are not efficiently cleared, this can promote further collateral cell death and permanent loss of contractile function. Our data reveal that MerTK-dependent phagocytic clearance ameliorates cardiac damage after reperfusion (Figure 1 ), but the full potential of cardiac MerTK is hampered by reperfusion-induced MerTK cleavage.
Our studies suggest that a potential trigger for MerTK cleavage is the CCR2-dependent recruitment of circulating Ly6C hi monocytes. CCR2 blockade reduced solMER levels and maintained surface MerTK on CCR2 − cardiac resident macrophages ( Figure 6 ). The concept that incoming monocytes trigger MerTK cleavage on resident cardiac macrophages is consistent with the protease and proinflammatory profile of Ly6C hi monocytes 30 ; however the mechanism of this phenomenon requires further study. For example, ADAM17/TACE (a disintegrin and metalloproteinase 17/TNF-α-converting enzyme), the protease that triggers MerTK cleavage, typically occurs in cis by juxtaposition to its target substrate. 31 Others have shown that atherosclerotic plaque contains microparticles with active ADAM17, which could also be a source of transderived proteases at sites of local infarction. 32 Alternative possibilities include paracrine activation of neighboring MerTK + cells. For example, MerTK cleavage can be triggered through several cell-intrinsic stimuli that lead to ADAM17 protease activation, including reactive oxygen species. 9 CCR2 signaling has been shown to promote reactive oxygen species production, and thus, monocyte-derived reactive oxygen species may activate ADAM17 on resident macrophages to promote MerTK cleavage. 33 Therefore, in addition to attenuating inflammation and preserving cardiac resident macrophages, 23 strategies aimed at inhibiting Ly6C hi monocyte recruitment to the injured heart may mediate their protective effects by limiting MerTK cleavage.
In addition to activation of actin-mediated engulfment of dying cells, MerTK crosslinking initiates intracellular signaling cascades that modulate macrophage cytokine production. 8 Deficiencies of MerTK reduced IL-10 and TGF-β production in cardiac and peritoneal macrophages after coculture with apoptotic cells (Figure 7 ; Online Figure VIII) . Both IL-10 and TGF-β have been implicated in cardiac remodeling and scarring post-MI. 34, 35 Interestingly, activation of MerTK signaling using an agonizing antibody alone was insufficient to induce IL-10 production or inhibit lipopolysaccharide-induced TNF-α secretion (Online Figure VIII) . Activation of MerTK using this agonizing antibody alone was previously shown to be insufficient to induce apoptotic cell phagocytosis, 36 and additional reports have demonstrated that macrophages may require additional extrinsic signals 37 or metabolic reprograming by the engulfed apoptotic cells 38 to fully modulate macrophage function. MerTK has also been shown to be dispensable during the inflammatory phase of peritonitis, 8 indicating that MerTK agonism may be functionally important in promoting inflammation resolution as opposed to limiting the initial extent of inflammation. Although not addressed in this study, MerTK activation also leads to the production of 12,15-LOX-derived specialized proresolving mediators. 8 Our unpublished findings after ELISA support a MerTK-specialized proresolving mediator axis in the heart; however, assays of higher specificity, such as LC-MS/ MS (liquid-chromatography tandem mass spectrometry), are required for confirmation. 39, 40 Thus, an additional benefit of protecting MerTK from I/R-associated cleavage is likely through its anti-inflammatory and proresolving function.
Unlike experimental permanent coronary occlusion, reperfusion protects resident cardiac macrophages from ischemic death. 16, 23 Strategies that block recruited phagocytes, 41 including from our own group, 17 ameliorate IRI. Resident cardiac macrophages have the capacity to self-renew under stress, 16 and it has been suggested that these embryonic-derived cardiac macrophages have increased cardioprotective capacity compared with monocyte-derived macrophages that establish residence in the heart after injury. 2, 3, 16 Our data suggest that MerTK is a critical regulator for activation and function of cardiac resident macrophages. Loss of MerTK reduced cardiomyocyte phagocytosis at both steady state and after I/R in resident macrophages (Figure 4) . Consistent with the concept that MerTK regulates resident macrophage function, inhibition of monocyte recruitment promoted cardiac repair in 
Mertk
+/+ hearts because MerTK cleavage was reduced, whereas inhibition of monocyte recruitment provided no benefit in Mertk −/− hearts ( Figure 5 ). These results indicate that strategies aimed at preserving resident macrophages to limit excessive inflammation and cardiac damage will also need to stabilize or preserve MerTK on these cells to maximize cardiac repair.
Our data also suggests that MerTK and MerTK-dependent phagocytosis are likely required for the maintenance and polarization of both resident macrophages at steady state and recruited monocyte-derived macrophages after injury in the heart. Phagocytosis has recently been demonstrated to imprint a distinct anti-inflammatory profile in tissue-resident macrophages, and this occurred in part because of phagocytosis of neutrophils. 42 However, cardiac tissue-resident macrophages were not included in this study, so the extent that this occurs in the heart is unknown. Neutrophils have been shown to drive polarization of proreparative, MerTK expressing macrophages in the infarcted myocardium, 43 and the levels of MerTK expression were inversely related to the numbers of neutrophils and the extent of injury after I/R (Figure 3) . Thus, MerTK-dependent phagocytosis may also be responsible for imprinting cardiac resident macrophages. For example, loss of MerTK reduces phagocytosis by resident macrophages at steady state and skews the population toward an MHCII HI CCR2 − population, which has been previously shown to be enriched for genes involved in antigen presentation and likely play a role in host defense against pathogens. 16 In contrast, MHCII LO CCR2 − cells, which possessed the highest levels of MerTK and displayed elevated levels of phagocytosis both at steady state and after injury, had enhanced anti-inflammatory cytokine production after injury (Figure 7) . Consistent with the concept that MerTK imprints cardiac macrophages, differentiation of MHCII HI CCR2 − to proreparative MHCII LO CCR2 − macrophages required MerTK because the absolute numbers of the MHCII LO CCR2 − population were severely diminished after injury to Mertk −/− hearts ( Figure 7) . However, the molecular signaling mechanisms that integrate phagocytosis of cardiomyocytes and other cells and imprint cardiac resident macrophage phenotype remain unknown, and further studies are required to address this important question.
That MerTK function and cleavage are both triggered in the acute perioperative hours after reperfusion renders these pathways particularly tractable for therapeutic intervention. Strategies to stabilize MerTK or prevent its cleavage and enhance phagocytosis may be a viable approach for enhancing cardiac protection post-I/R in humans. Furthermore, our findings suggest that monitoring solMER levels after IRI in humans should inform novel therapeutic approaches to improving cardiac repair and limiting the progression to heart failure. Because elevated levels of solMER were measured in human plasma after STEMI (Figure 2 ) and that the extent of MerTK cleavage correlated with poor cardiac repair in mice, solMER might serve as a useful biomarker for interventions that aim to reduce IRI in humans. 
